Schedule 13G ownership disclosure

UROGEN PHARMA LTD

Ordinary Shares, par value NIS 0.01 per share · CUSIP: M96088105

Event date: 2025-06-09

Filing-level shares
2,652,500
Percent of class
5.8%
  • Cowen Financial Products LLC

    Shares: 2,652,500 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-25-003449
Form type
SCHEDULE 13G
Filer
Cowen Financial Products LLC
CIK
CIK 1771015
Filed
Jun 13, 2025
Reporting period
Jun 09, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub